MTOR and non-small cell lung carcinoma: Besides these effects, mTOR activity–dependent alterations can induce protein expression (e.g., that of BMP2 and Sestrin2) and promote EMT and metastasis in different cancer models (ovarian, nasopharyngeal, pancreatic cancer, NSCLC, and HCC) [307].